| Literature DB >> 22065947 |
Sharon Margriet Kolk1, Annetrude Johanne de Mooij-Malsen, Gerard Julianus Maria Martens.
Abstract
We have only just begun to decipher the complexity of our brain, including its maturation. Correct brain development and communication among brain areas are crucial for proper cognitive behavior. Brain area-specific genes expressed within a particular time window direct neurodevelopmental events such as proliferation, migration, axon guidance, dendritic arborization, and synaptogenesis. These genes can pose as susceptibility factors in neurodevelopmental disorders eventually resulting in area-specific cognitive deficits. Therefore, in utero electroporation (IUE)-mediated gene transfer can aid in creating valuable animal models in which the regionality and time of expression can be restricted for the targeted gene(s). Moreover, through the use of cell-type-specific molecular constructs, expression can be altered in a particular neuronal subset within a distinct area such that we are now able to causally link the function of that gene in that brain region to the etiology of the disorder. Thus, IUE-mediated gene transfer is an attractive molecular technique to spatiotemporally address the developmental aspects of gene function in relation to neurodevelopmental disorder-associated endophenotypes.Entities:
Keywords: animal model; axon guidance; gene transfer; in utero electroporation; migration; neurodevelopment
Year: 2011 PMID: 22065947 PMCID: PMC3206543 DOI: 10.3389/fnmol.2011.00037
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Figure 1Spatial confinement to areas involved in neurodevelopmental disorders using in utero electroporation (IUE) -mediated gene transfer. (A) Schematic representation of IUE into three areas (1) the hippocampus, (2) the prefrontal cortex, (3) the striatum. On the left side, a sagittal view is shown indicating the level of the coronal section (dotted line) shown on the right side where the position of the + and − poles is indicated. IUE is performed at embryonic day 14.5 (E14.5) and embryos are left undisturbed for 4 days in utero (diu) before sacrifice (sac) at E18.5. Arrowheads indicate various neurodevelopmental events. (B) E18.5 coronal cryosection of an electroporated mouse brain (E18.5–4diu). Control construct CMV–YFP–N1 (green) is electroporated into the hippocampal anlage enlarged in (B′) (boxed area), counterstained with the layer V marker Ctip2 (red) and fluorescent Nissl (blue). (C) Electroporation was performed into the whole span of the medial prefrontal cortex (mPFC) including the infralimbic (IL), prelimbic (PL), and cingulate cortex (Cg). Boxed area is enlarged in (C′). (D) Electroporation was performed into the ventricular zone (VZ) of the caudate putamen (CP) close to the external capsule (EC). Boxed area is enlarged in (D′). CA1, cornu ammonis 1; CA3, cornu ammonis 3; Cg, cingulate cortex; Ctx, cortex; DG, dentate gyrus; EC, external capsule; Hb, habenula; Str, striatum.
Figure 2Temporal restriction of gene introduction during various neurodevelopmental events. (A) Schematic representation of the proliferation paradigm using in utero electroporation (IUE). Two hours prior to sacrifice (sac), BrdU is injected to label dividing cells. (B) E15.5 coronal section showing the cerebral cortex with in red the BrdU-labeled cells within the proliferative zone (PZ) and in green the CMV–YFP–N1 construct (YFP), counterstained with fluorescent Nissl (blue) 1 day after IUE (1 diu). (C) Confocal image of YFP-labeled neurons and radial glia (green) co-stained with the radial glia marker RC2 (red). Arrowhead indicates a migrating neuron “climbing the robe” of a radial glia. (D) Schematic representation of the migration paradigm using IUE. Just after surgery BrdU is injected to label dividing cells and “birthdate” them. (E) E17.5 coronal section showing the cerebral cortex with BrdU-labeled cells (red) that have migrated to a certain position within the cortical plate (CP) combined with a YFP control construct (green), counterstained with fluorescent Nissl (blue) 3 days after IUE (3 diu). As soon as the YFP-positive neurons become post-mitotic they start to migrate and can be double labeled with BrdU (yellow). (F) Is an enlargement of the boxed area in (E). (G) E18.5 coronal section showing an YFP-labeled (green) somatosensory cortex (S1) projecting toward the other hemisphere through the corpus callosum (CC) counterstained with superficial layer marker Satb2 (red) and fluorescent Nissl (blue). (H) Is an enlargement of the projections through the CC in (G). (I) P24 coronal section showing YFP-positive pyramidal neurons (green) in layer IV of the S1 on top of the layer V marker Ctip2 (red). (J) Network formation of YFP-positive pyramidal neurons with extended dendritic branches and axonal projections. Counterstained with Ctip2 (red) en fluorescent Nissl (blue).
Figure 3Constructs for use in . (A) Schematic representation of the most frequently used constructs that can be constitutively expressed under either a ubiquitous promoter (e.g., CMV, cytomegalovirus; EF1, elongation factor 1; ROSA, ROSA26 TATA-less promoter; CAG, chicken actin combined with CMV enhancer) or a cell-type-specific promoter (e.g., Thy1, THYmocyte differentiation antigen 1 driving expression in axons of neurons; Nestin, neuronal stem cell tubulin neuronal promoter; Tα1, α-tubulin neuronal promoter; BLBP, brain lipid-binding protein radial glial specific promoter; GLAST, glutamate–aspartate transporter radial glial/astrocytic promoter; CAMKII, calcium/calmodulin-dependent kinase II neuronal promoter specific for forebrain; Synapsin, neuronal promoter; DCX, doublecortin neuroblast-specific promoter; NSE, neuron-specific enolase drives expression in neurons and to some extent in glial cells; ER81, ETS family transcription factor driving expression in specific subset of neurons; Ngn2, neurogenin2 driving expression in neurons; TH, tyrosine hydroxylase dopaminergic neuron-specific promoter). These promoters can drive expression of among others full-length (FL) constructs, dominant-negative (DN) constructs or, e.g., shRNAs of genes of interest (GOI) to establish knockdown via RNAi. The reporter element can be either a fluorescent protein ranging from far red, red, orange, yellow, green, or cyan fluorescence or LacZ. Often enhancer elements (e.g., SV40, NFkB, NFAT, ISRE, or p53) are used, but this is not always essential to drive the expression. Electroporation constructs are all terminated with a polyA tail. (B) Schematic representation of the commonly used inducible constructs such as the Cre-reporter construct expressed under an ubiquitous or a cell-type-specific promoter. The GOI containing construct can be under the control of an ubiquitous promoter (usually CAG) a neomycin (neo)-cassette that is floxed (loxP before and after) and thus excised upon addition of tamoxifen at a specific time point in development. (C) Example of a knockdown experiment using IUE with an off-target construct (control) and RNAi against the doublecortin-like gene (pSuper-DCL183 or DCLi). Both in the proliferative zone (PZ) as well as in the intermediate zone (IZ) and cortical plate (CP) neurons are reduced in number and the radial fibers are severely disrupted. Green is the construct, red is a β-tubulin staining (Tuj1). Adapted from Vreugdenhil et al. (2007).